Single-centre, single-dose, open-label, randomised, four-way cross-over study to evaluate and compare the pharmacokinetic parameters of a fixed dose combination of intravenous acetaminophen + intravenous ibuprofen, intravenous acetaminophen, intravenous ibuprofen and a fixed dose combination tablet of acetaminophen 325mg + ibuprofen 97.5mg, in healthy volunteers.

Trial Profile

Single-centre, single-dose, open-label, randomised, four-way cross-over study to evaluate and compare the pharmacokinetic parameters of a fixed dose combination of intravenous acetaminophen + intravenous ibuprofen, intravenous acetaminophen, intravenous ibuprofen and a fixed dose combination tablet of acetaminophen 325mg + ibuprofen 97.5mg, in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2016

At a glance

  • Drugs Ibuprofen/paracetamol (Primary) ; Ibuprofen/paracetamol (Primary) ; Ibuprofen; Paracetamol
  • Indications Pain
  • Focus Pharmacokinetics
  • Acronyms Maxi-IV PK
  • Sponsors AFT Pharmaceuticals
  • Most Recent Events

    • 04 Aug 2016 Status changed from not yet recruiting to completed.
    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top